Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY NASDAQ:MDAI NASDAQ:SMTI NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$11.76-0.6%$11.85$6.65▼$13.65$222.26M1.4246,130 shs39,211 shsMDAISpectral AI$2.44+1.7%$2.38$0.82▼$3.25$61.78M0.9465,072 shs245,612 shsSMTISanara MedTech$24.80+1.8%$27.66$23.53▼$39.08$220.47M1.2647,600 shs37,206 shsTCMDTactile Systems Technology$12.28-1.3%$10.26$8.61▼$21.10$273.72M0.96255,382 shs225,255 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%+2.53%-4.47%+33.18%+68.24%MDAISpectral AI0.00%+3.39%-14.69%+79.41%+61.59%SMTISanara MedTech0.00%+2.65%-14.66%-27.84%-11.05%TCMDTactile Systems Technology0.00%+27.25%+23.29%+26.34%-7.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBWAYBrainsway2.8732 of 5 stars2.55.00.00.02.40.81.9MDAISpectral AI2.2922 of 5 stars3.72.00.00.01.23.30.0SMTISanara MedTech1.5699 of 5 stars3.51.00.00.00.61.70.6TCMDTactile Systems Technology2.1532 of 5 stars1.21.00.00.03.82.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 3.00Buy$14.2521.17% UpsideMDAISpectral AI 3.33Buy$4.7594.67% UpsideSMTISanara MedTech 3.00Buy$49.5099.60% UpsideTCMDTactile Systems Technology 2.40Hold$13.509.93% UpsideCurrent Analyst Ratings BreakdownLatest MDAI, TCMD, BWAY, and SMTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/5/2025TCMDTactile Systems TechnologyWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy8/5/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$12.00 ➝ $13.006/9/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.005/15/2025SMTISanara MedTechHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$51.00 ➝ $53.00(Data available from 8/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$41.02M5.42$0.25 per share47.16$3.31 per share3.55MDAISpectral AI$29.58M2.09N/AN/A($0.32) per share-7.63SMTISanara MedTech$86.67M2.54N/AN/A$4.45 per share5.57TCMDTactile Systems Technology$292.98M0.93$1.08 per share11.35$9.03 per share1.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$2.92M$0.2058.8073.50N/A9.01%7.35%4.72%8/13/2025 (Estimated)MDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%8/12/2025 (Estimated)SMTISanara MedTech-$9.66M-$1.34N/AN/AN/A-12.48%-29.22%-13.20%8/13/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6219.8114.62N/A5.06%7.72%5.59%N/ALatest MDAI, TCMD, BWAY, and SMTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025BWAYBrainsway$0.07N/AN/AN/A$12.34 millionN/A8/13/2025Q2 2025SMTISanara MedTech-$0.33N/AN/AN/A$25.15 millionN/A8/12/2025Q2 2025MDAISpectral AI-$0.07N/AN/AN/A$5.44 millionN/A8/4/2025Q2 2025TCMDTactile Systems Technology$0.09$0.14+$0.05$0.14$73.93 million$78.91 million5/14/2025Q1 2025SMTISanara MedTech-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million5/13/2025Q1 2025BWAYBrainsway$0.02$0.04+$0.02$0.04$11.45 million$11.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A5.034.75MDAISpectral AIN/A1.411.37SMTISanara MedTech1.182.772.54TCMDTactile Systems Technology0.113.793.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%MDAISpectral AI67.08%SMTISanara MedTech8.10%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%MDAISpectral AI30.70%SMTISanara MedTech42.60%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12018.90 million15.31 millionNot OptionableMDAISpectral AI8325.32 million17.55 millionNot OptionableSMTISanara MedTech608.89 million5.10 millionNot OptionableTCMDTactile Systems Technology1,03722.29 million21.74 millionOptionableMDAI, TCMD, BWAY, and SMTI HeadlinesRecent News About These CompaniesKoss Olinger Consulting LLC Takes Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)4 hours ago | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Given Average Rating of "Hold" by Analysts5 hours ago | americanbankingnews.comBlair William & Co. IL Reduces Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)August 10 at 4:17 AM | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Upgraded by Wall Street Zen to Buy RatingAugust 10 at 2:50 AM | marketbeat.comWhat is B. Riley's Estimate for TCMD Q1 Earnings?August 8 at 9:36 AM | marketbeat.comQ3 Earnings Forecast for TCMD Issued By William BlairAugust 8 at 8:02 AM | marketbeat.comEquities Analysts Issue Forecasts for TCMD Q1 EarningsAugust 8 at 4:05 AM | americanbankingnews.comWhat is B. Riley's Forecast for TCMD Q3 Earnings?August 8 at 2:09 AM | americanbankingnews.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from AnalystsAugust 7, 2025 | marketbeat.comWilliam Blair Upgrades Tactile Systems Technology (NASDAQ:TCMD) to Strong-BuyAugust 7, 2025 | marketbeat.comB. Riley Analysts Reduce Earnings Estimates for TCMDAugust 7, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comTactile Systems Technology (NASDAQ:TCMD) Earns "Neutral" Rating from B. RileyAugust 7, 2025 | americanbankingnews.comB. Riley Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock PriceAugust 6, 2025 | marketbeat.comIs Tactile Systems Technology (TCMD) Stock Undervalued Right Now?August 6, 2025 | zacks.comTactile Systems Technology (TCMD) Just Overtook the 20-Day Moving AverageAugust 6, 2025 | zacks.comTactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving AverageAugust 6, 2025 | zacks.comTactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growthAugust 6, 2025 | msn.comTactile Systems Technology (NASDAQ:TCMD) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPSAugust 5, 2025 | marketbeat.comTactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comTactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue EstimatesAugust 4, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMDAI, TCMD, BWAY, and SMTI Company DescriptionsBrainsway NASDAQ:BWAY$11.76 -0.07 (-0.59%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$12.12 +0.36 (+3.06%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Spectral AI NASDAQ:MDAI$2.44 +0.04 (+1.67%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.46 +0.02 (+0.78%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Sanara MedTech NASDAQ:SMTI$24.80 +0.44 (+1.81%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$24.68 -0.12 (-0.50%) As of 08/8/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Tactile Systems Technology NASDAQ:TCMD$12.28 -0.16 (-1.29%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$12.21 -0.07 (-0.57%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.